Nuwellis

Nuwellis is a medical device company that develops, manufactures and commercializes ultrafiltration systems for the treatment of fluid overload in patients with cardiorenal conditions, including heart failure. Its Aquadex SmartFlow and Aquadex FlexFlow systems provide extracorporeal fluid removal in adult and pediatric patients, positioning the company in the critical-care and cardiac markets where diuretic resistance is common. The company was formerly known as CHF Solutions and was renamed Nuwellis in April 2021; it is headquartered in Eden Prairie, Minnesota with approximately 38 employees. Nuwellis reports commercial progress in terms of console placements - it disclosed 31 Aquadex SmartFlow consoles sold year-to-date in 2026, a pace exceeding full-year console sales in seven of the past ten years - and has funded operations through registered direct offerings under a shelf registration statement.